News about "Samsung Biologics"

Samsung Biologics Announces Manufacturing Deal with European Pharmaceutical Company

Samsung Biologics Announces Manufacturing Deal with European Pharmaceutical Company

Samsung Biologics is set to add antibody-drug conjugate (ADC) services to its portfolio, with a dedicated facility to be completed by the end of this year.

Samsung Biologics | 20/11/2024 | By Aishwarya

Samsung Biologics Secures ISO Certifications for its Business Excellence

Samsung Biologics Secures ISO Certifications for its Business Excellence

The certifications were presented by the British Standards Institution (BSI) during a ceremony held at Samsung Biologics' headquarters.

Samsung Biologics | 11/11/2024 | By Aishwarya 118

Samsung Biologics Inks Manufacturing Deal with Asian Pharmaceutical Company

Samsung Biologics Inks Manufacturing Deal with Asian Pharmaceutical Company

With the latest agreement, the company's accumulated contract for 2024 surpasses USD 3.3 billion.

Samsung Biologics | 22/10/2024 | By Aishwarya 122

Samsung Biologics Develops High-Concentration Formulation Platform for Drug Development

Samsung Biologics Develops High-Concentration Formulation Platform for Drug Development

S-HiCon can proactively identify unintended pH changes, enhance formulation stability, and reduce viscosity to ensure efficacy and maximize drug delivery.

Samsung Biologics | 15/10/2024 | By Aishwarya 142

Samsung Biologics Introduces Development Platforms for Enhanced Therapeutic Efficacy

Samsung Biologics Introduces Development Platforms for Enhanced Therapeutic Efficacy

Samsung Biologics has unveiled a series of proprietary development platforms as part of continued efforts to ensure high-quality development and provide client-tailored services.<br />

Samsung Biologics | 26/09/2024 | By Aishwarya 171

Samsung Biologics Joins Pharmaceutical Supply Chain Initiative as Supplier Partner

Samsung Biologics Joins Pharmaceutical Supply Chain Initiative as Supplier Partner

Samsung Biologics, a global contract development and manufacturing organization (CDMO), has joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner.

Samsung Biologics | 08/08/2024 | By Aishwarya 161

Samsung Biologics set to begin construction of new $1.5B plant

Samsung Biologics set to begin construction of new $1.5B plant

The investment will add 180,000 litres of capacity to the complex in Incheon, bringing total capacity to 784,000 litres, the most at a single site in the industry

Samsung Biologics | 03/05/2023 | By Sudeep Soparkar 362

Samsung Biologics eyes strategic expansion in Korea

Samsung Biologics eyes strategic expansion in Korea

The company plans to begin construction in the first half of 2023 and commence operations in 2025
<br />

Samsung Biologics | 21/03/2023 | By Sudeep Soparkar 417


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members